1. β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models
- Author
-
Doblin Sandai, Marawan Ahmed, Muhammad Asif, Arno G. Siraki, Saad Sabbar Dahham, Yasser M Tabana, Khaled Barakat, Dinesh Babu, Mohamed B. Khadeer Ahamed, Loiy Elsir Ahmed Hassan, and Amin Malik Shah Abdul Majid
- Subjects
Male ,Beta-Caryophyllene ,QH301-705.5 ,Angiogenesis ,Mice, Nude ,Apoptosis ,colorectal cancer ,Chick Embryo ,Catalysis ,Umbilical vein ,Chorioallantoic Membrane ,Article ,Inorganic Chemistry ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,angiogenesis ,Downregulation and upregulation ,Cell Movement ,Survivin ,Human Umbilical Vein Endothelial Cells ,Animals ,Humans ,Biology (General) ,Physical and Theoretical Chemistry ,QD1-999 ,Molecular Biology ,Spectroscopy ,Cells, Cultured ,Cell Proliferation ,Polycyclic Sesquiterpenes ,Neovascularization, Pathologic ,xenograft nude mice ,Chemistry ,Organic Chemistry ,Anti-Inflammatory Agents, Non-Steroidal ,General Medicine ,HCT116 Cells ,Xenograft Model Antitumor Assays ,Computer Science Applications ,XIAP ,Vascular endothelial growth factor ,Chorioallantoic membrane ,VEGFR2 ,Microvessels ,Cancer research ,Colorectal Neoplasms - Abstract
Beta-Caryophyllene (BCP), a naturally occurring sesquiterpene abundantly found in cloves, hops, and cannabis, is the active candidate of a relatively new group of vascular-inhibiting compounds that aim to block existing tumor blood vessels. Previously, we have reported the anti-cancer properties of BCP by utilizing a series of in-vitro anti-tumor-related assays using human colorectal carcinoma cells. The present study aimed to investigate the effects of BCP on in-vitro, ex-vivo, and in-vivo models of anti-angiogenic assays and evaluate its anti-cancer activity in xenograft tumor (both ectopic and orthotopic) mice models of human colorectal cancer. Computational structural analysis and an apoptosis antibody array were also performed to understand the molecular players underlying this effect. BCP exhibited strong anti-angiogenic activity by blocking the migration of endothelial cells, tube-like network formation, suppression of vascular endothelial growth factor (VEGF) secretion from human umbilical vein endothelial cells and sprouting of rat aorta microvessels. BCP has a probable binding at Site#0 on the surface of VEGFR2. Moreover, BCP significantly deformed the vascularization architecture compared to the negative control in a chick embryo chorioallantoic membrane assay. BCP showed a remarkable reduction in tumor size and fluorescence molecular tomography signal intensity in all the mice treated with BCP, in a dose-dependent relationship, in ectopic and orthotopic tumor xenograft models, respectively. The histological analysis of the tumor from BCP-treated mice revealed a clear reduction of the density of vascularization. In addition, BCP induced apoptosis through downregulation of HSP60, HTRA, survivin, and XIAP, along with the upregulation of p21 expressions. These results suggest that BCP acts at multiple stages of angiogenesis and could be used as a promising therapeutic candidate to halt the growth of colorectal tumor cells.
- Published
- 2021
- Full Text
- View/download PDF